Stryker Receives FDA Clearance for Bone Tumor Ablation System
Stryker, a medical tech company, announced its OptaBlate bone tumor ablation system (OptaBlate) received 510(k) clearance from the U.S. FDA.
Stryker, a medical tech company, announced its OptaBlate bone tumor ablation system (OptaBlate) received 510(k) clearance from the U.S. FDA.
Stryker is notifying a population of LifePak 15 customers of an issue that may cause their devices to fail to deliver a defibrillation shock after the “Shock” button on the keypad is pressed.
Stryker, a medical tech company, announced its OptaBlate bone tumor ablation system (OptaBlate) received 510(k) clearance from the U.S. FDA.